Introduction
Artemisinin (ART) and its derivatives are widely used throughout the world. ART is an end peroxide-containing sesquiterpene developed from an ancient Chinese herbal remedy, which was used by Chinese herbal medicine practitioners for at least 2000 years. 1 ART has been of special biological interest for many years. Because of its strong cytotoxic activity, it was reported that ART has special antitumor activity against melanoma, breast, ovarian, prostate, central nervous system, and renal cancer celllines. [2] [3] [4] However, ART presents some problems: ART has low bioavailability due to its low solubility; ART metabolizes quickly in vivo and has an initial burst effect and high peak plasma concentrations; ART is not very stable and easily decomposes, most probably by the opening of the lactone ring, due to its unusual peroxy group: it is difficult for drug crystals to disperse homogeneously in solution or blood because of their hydrophobicity; and a greater number of injections is necessary because of the short-duration effect. These problems can potentially be overcome by developing a controlled release scheme. Consequently, it is very important to prepare ART micro-or nanocapsules to increase their in vitro dissolution and to prolong their release time. However, there are a few literature reports on encapsulation of ART, particularly ART nanomicelles. Gharib, et al, Prepared magnetic nanoliposomes and characterized for delivery of artemisinin and transferring. 5 However, there are few literature reports on encapsulation of ART, especially nanoscale ART. [6] [7] Li and Zhou prepared a solid dispersion of ART using solid-dispersion technique to improve bioavailability of its dosage form. 8 To achieve drug controlled release, biodegradable polymeric nanoparticles are often used in advanced anticancer drug delivery systems. [9] [10] [11] [12] Some drug delivery systems via biodegradable polymers such as nanoparticles delivering anticancer agents are commercially available. [13] [14] Micelles as drug carriers welfare some benefits such as increased bioavability, reduced toxic side effects, possibility for attachment of targeting moieties, storage stability, long blood circulation time, and lower contacts with reticuloendothelial system (RES). [15] [16] [17] Moreover the most significant feature of micelles is that in spite of other drug carriers they can be used for both hydrophilic and hydrophobic drugs. This is because of amphiphilic nature of micelles which cause the drug molecule to be located in dissimilar micellar sections depending on hydrophobichydrophilic balance of drug molecule and, hence, associate with the micelle with varying affinities. Diblock copolymer of methoxypoly (ethylene glycol)-poly (caprolactone) (mPEG-PCL) is a good candidate to prepare micelle-like nanomicelles with the hydrophobic PCL block and hydrophilic mPEG block. 18 The hydrophobic core can serve as reservoir for hydrophobic drugs and mPEG shell play a dual role in stabilizing particles and associating with hydrophilic drugs. Poly (caprolactone) -poly (ethylene glycol) (PCL-PEG) copolymers are biodegradable, easy to produce, amphiphilic, and have a strong potential application in drug delivery systems. [19] [20] [21] [22] The purpose of this research is to minimize the doses amount, toxicity and to improve the therapeutic efficacy by formulating ART nanoparticles. For this reason, it seems that encapsulating of artemisinin in mEEG-PCL micelles could be a novel delivery vehicle for artemisinin in vitro cancer therapy.
Materials and Methods

Materials
Artemisinin (98% purity), stannous 2-ethylhexanoate (Sn (Oct) 2), mPEG (Mn=5000 Da), ε-caprolactone (98% purity), Methanol, acetonitrile, acetone, ethanol, and the other chemicals and solvents were was shown in Table 1 .
Synthesis of mPEG-PCL copolymer
The synthesis of mPEG-PCL copolymers was performed by a ring opening polymerization of ε-caprolactone with mPEG as initial molecule and Sn (Oct) 2 as catalyst. [23] [24] [25] mPEG was kept under a high vacuum at 80 °C for 2 hours(h) to remove all moisture. Briefly, ε-caprolactone (5 g), mPEG (2.5 g), and Sn (Oct) 2 (0.01 mmol) were heated to 120 °C under a nitrogen atmosphere. The polymerization reaction was performed under stirring situations. After 12 h, the resulting product was cooled to room temperature (23°C), dissolved in dichloromethane, and precipitated in cold diethyl ether. Then the mixture was filtered and the purification process was repeated twice more. The obtained di block copolymer was dried under vacuum at room temperature for 24 h. 
Preparation of micelles
Artemisinin loaded micelles were prepared by nanoprecipitation process and acetone was used as the solvent. [23] [24] [25] mPEG-PCL copolymer (20 mg) and artemisinin (6 mg) were dissolved in 2 ml of acetone. The solution was added drop-wise through a syringe (G=22) into 25 ml of distillated water under certain mixing rates (1500 rpm) and was continuously stirred magnetically at room temperature to evaporate all the organic solvent. Micelles were obtained by self-associating of amphiphilic mPEG-PCL copolymers. The micelles were separated by centrifuging at 20000 g for 20 min and freeze-dried under a pressure of 14(paskal) Pa at -78 °C to remove the residual solvent to obtain the final dried form.
Physicochemical Characterization of the micelles Particle morphology
Atomic Force Microscopy (AFM) (JPK, Berlin, Germany, and model Nano Wizard 2) was used for evaluation of nanomicelles morphology. For AFM sample preparation, micelles were diluted with water and a droplet of 2 μL was placed onto a freshly cleaved mica substrate (1 cm 2 ) and air-dried. AFM measurements were performed in intermittent contact mode.
Determination of particle size and zeta potential of artemisinin loaded micelles Dynamic Light Scattering (DLS) using a nano/zetasizer (Malvern Instruments, Worcestershire, UK, model Nano ZS) was used for determination of the particle size distribution and zeta potential of the prepared micelles (1 mg/ml).
Stability study of micelles
Stability of micelles was evaluated by monitoring the size of the micelles in phosphate-buffer saline(PBS, pH=7.4) at ambient temperature at times 0, 15, and 30 days after preparation using the method described in section of preparation of micelles.
Drug loading and encapsulation efficiency
Drug loading and encapsulation efficiency of micelles were evaluated be equations 1 and 2. Drug loading (DL) efficiency was evaluated by equation 1.
Wdrug in micelles and Wmicelles show weight of the encapsulated drug and the total weight of the corresponding drug-encapsulated micelles, respectively. DL% is the drug loading ratio (%). For assessment of the drug loading efficiency, 1 mg of the final freeze-dried nanomicelles was dissolved in 1mLof dichloromethane. Drug loading was determinated by high performance liquid chromatography (HPLC). A C8 analytical column (150 mm ×4.6 mm, 5 micron) equipped with a guard column of the same packing was used. The mobile phase was consisted of acetonitrile and water in the volume ratio of 60:40, and was delivered at a flow rate of 1.0 ml/min using a double-reciprocating pump and the analysis wavelength was at 210 nm (Waters, MA, USA, model Breeze). The sample was injected through a 20 μL sample loop. Encapsulation efficiency was evaluated using the following equation 2: 
DSC analysis
Any possible drug-polymer interaction(s) as well as the physical changes occurred on the drug or polymer can be studied using the thermal analysis. DSC analysis was carried out on pure drug and drug-loaded micelles. Samples were heated at a rate of 10 ° C min −1 and the data were documented from 0 to 200 °C.
In vitro drug release study
This test was performed to measure the release behavior of artemisinin from nanomicelles. At first, 5 mg of artemisinin loaded micelles was dispersed in 2 mL PBS with pH= 7.4 containing 5% (v/v) Tween 80 and the resulting suspension was placed within a dialysis sac (MW 12 kDa) and incubated at 37 °C while immersed in 15 ml of PBS. Then, at predetermined time intervals, 3 ml of the dialysate was taken out and replaced by 3 mL fresh PBS.
The concentration of artemisinin in the dialysate was determined by HPLC method at the wavelength of 210 nm. 26 All the release studies were performed in triplicate. As the release control, the release of free artemisinin was measured in PBS at pH= 7.4. To determine the pH-dependency of the drug release, the study was also carried out, as specified earlier, using PBS with pH of 5.5. To evaluate the drug release behavior of carriers while incubated in real human plasma, the release experiments were repeated in plasma of a healthy male volunteer in the same condition except that the samples were incubated in plasma as a substitute of PBS.
Results
Synthesis and characterization of mPEG-PCL copolymer
Diblock copolymers were successfully synthesized using the ring-opening polymerization of caprolactone in presence of PEG, whose hydroxyl end group initiated the ring opening. Characterization of the mPEG-PCL di-block copolymer structure was evaluated by HNMR spectroscopy in CDCl3 (Figure 1 ). The presence of methylenes (CH2) in PCL was observed around 1.4 (i,j)ppm, 1.7(h) ppm, 2.4(g) ppm and 4.1(k) ppm, the methoxy and methylene protons in methoxy(OCH3) (f)and methylene (CH2) groups(a) of PEG were around 3.39 and 3.7 ppm.). NMR results showed that the average molecular weights of copolymer were 16.1. FT-IR spectrum of mPEG-PCL copolymer has been shown in Figure  2 . The sharp and intense bands at 1725 cm −1 and 1109 cm −1 were attributed to the presence of carboxylic ester (C=O) and ether (C-O) groups, The signals at 2995 and 2891cm -1 were assigned to the absorption of the C-H stretching bonds of -CH2CH2, which are similar to those of ε-CL. The signals at 1430 and 1325 cm -1 were assigned to the bending bonds of C-H of CH2 of caprolactone , the signal of 3500 cm -1 was assigned to the O-H band.
Preparation and characterization of copolymeric micelles AFM was used for confirmation of nanomicelles. As expected for the micelles, the mPEG-PCL copolymeric micelles showed a homogeneous spherical morphology (Figure 3 ).The size of copolymric micelles measured by AFM was about 110.34 nm. The size of micelles measured by AFM was smaller comparing to measuring by DLS, because the size measured by AFM is related to the collapsed micelles after water evaporation while micelles diameter measured by DLS represents their hydrodynamic diameter. The size and zeta potential of prepared micelles was also measured by dynamic light scattering technique ( Figure   4 ).The size and Zeta potential of artemisinin loaded micelles were about 142.9 nm and -4.93 mV, with their corresponding PDI being 0.142. The encapsulation efficiency and loading efficiency of artemisinin loaded copolymeric micelles were determined 63±2.31%, and 15% ± 1.43% respectively (Table2).
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Nanoparticles for delivery of artemisinin Figure 5 shows the DSC thermograms corresponding to mPEG-PCL copolymer, artemisinin and micelles loaded by artemisinin. The thermogram of mPEG-PCL copolymer displayed an endothermic peak at 52.34 º C which is indicative for the melting of the crystalline PCL segment of copolymer, the thermogram of artemisinin displayed an endothermic peak at 154.35 º C and micelles displayed an endothermic peak at 45.08 0 C which related to the melting of copolymers associated in the form of micelles. This endothermic peak of micelles presumably confirms a physical interaction between copolymer and artemisinin upon loading of the drug in micelles, since the melting point of PCL micelles was lower than melting point of copolymer (58.68 º C). The characteristic peak of artemisinin was not observed in micelles. It could be concluded that the ART in the micelles was in an amorphous or disordered crystalline phase or in a solid solution state.
DSC analysis
Artemisinin release from micelles impacted by different release media Study of artemisinin release was determined on artemisinin-loaded nanomicelles in neutral and acidified PBS solution (pH=5.5). The release of free artemisinin was evaluated to verify that the diffusion of drug molecules across the dialysis membrane was not a rate-limiting step during the release process. The free artemisinin to released rapidly and reached to70.95% of the total amount in 12 h. The release profiles of artemisinin from the artemisinin-loaded micelles, at pH 7.4, 5.5, and plasma was showed at Figure 6 . No considerable initial artemisinin burst release was observed from the micelles. As it can see in Figure 6 , with pH decreasing from 7.4 to 5.5, the artemisinin release from micelles was increased. For example, percentage of artemisinin released from the micelles after 72 h incubation, in the media with pH values of 7.4, 5.5 and human plasma were about 46.23, 42.32, and 49.32%, respectively, Figure 6 shows that the maximum artemisinin releases form the nanomicelles is 60.99%, 65.56% and 66.54% for PBS pH=7.4, pH=5.5 and plasma after a period of 96 h respectively. The reason of artemisinin sustained release can be related to the entrapment of artemisinin in inner part of micelles or the core of micelles. Therefore, our nanomicelles could be a highly attractive nanomicelles for drug delivery of hydrophobic drugs for the achievement of different therapeutic objectives
Physical stability of micelles
In the clinical administration of nanoparticle dispersions, the stability of the sizes of the nanomicelles is of great importance both as a measure of the particle structure integrity and as an indicator of the possible inter-particular Pharmaceutical Sciences, December 2016, 22, 234-243 | 239 associations (aggregation). For this purpose, the particle size stability was monitored in this study over a 30-days course. The variation of the sizes of nanomicelles as a function of incubation time is shown in Table 3 . As it can be seen, the size of all micelles was increased slightly throughout the measurement period. This observation cannot be a sign of aggregation, which usually leads to several fold increases. Probably some kind of copolymer swelling and/or hydration as a result of presence of the hydrophilic PEG portions in nanomicelles surfaces can be responsible for this event. 
Discussion
Artemisinin is a sesquiterpene lactone and phytochemical found naturally in Artemisia annua L. 1 Data for artemisinin's advantage was attributed for anti-malaria, anti-oxidative, anti-inflammatory, and anti-cancer effects. 2, 5 It is reported that the anticancer effect of artemisinin was increased several fold in the presence of iron sources such as transferring. 3 In this study, we evaluated the probable of loading artemisinin into nanomicelles. We found that the encapsulation efficiencies of artemisinin in the nanomicelles were suitable. Amphiphilic nature of mPEG-PCL with hydrophilic PEG and hydrophobic PCL blocks provides an opportunity to form micelles in water. This behavior can be explained as a consequence of copolymer self-assembling into micellar structure because of its amphiphilic nature which, subsequently forces the hydrophilic PEG segments to serve as hydrophilic shell and the hydrophobic PCL segments to become the micellar core. The ART/mPEG-PCL micelles having a minor negative surface charge of −4.93 mV can increase the circulation time of the drug. Surface charge is important in determining whether the nanomicelles will cluster in blood flow or will stick to or interact with oppositely charged cell membrane. The plasma and blood cells constantly have a negative charge; nanomicelles with slight negative surface charge can minimize nonspecific contact with these components through electrostatic interactions. [27] [28] [29] [30] The release is faster in acidic pH than in neutral, as in acidic environment the polymer matrix swells due to protonation of polymer. This behavior is a highly desirable characteristic in many applications especially in anticancer drug delivery where the micro-environments of extracellular spaces of tumors, intracellular lysosomes and endosomes are acidic, which can potentially facilitate the drug release from obtained micelles. Therefore, the obtained copolymeric micelles can be regarded as highly attractive nanomicelles for drug delivery of hydrophobic drugs to attainment of different therapeutic objectives.
Conclusion
With the potential managing as drug carriers for mPEG-PCL di block copolymer micelles in delivery systems, the efficacy of the micelles for the entrapment and controlled release of ART were investigated. The mPEG-PCL copolymers were self-assembled into micelles in aqueous solution in presence of artemisinin. The resulting micelles were characterized by various techniques such as DLS and AFM. The encapsulation efficiency and loading efficiency of artemisinin to these micelles is very good. In vitro release of artemisinin from artemisinin-entrapped micelles was clearly sustained in all the media tested for this purpose. The results of AFM revealed that the micelles formed had spherical structure. In summary the results suggested that the ART/mPEG-PCL micelles is suitable candidate for delivery of ART and may have potential application in cancer treatment.
